A Phase IIb Trial to Test Safety, Immunogenicity and Efficacy of Blood Stage Malaria Vaccine.
Condition: Malaria,Falciparum Interventions: Biological: Rabies vaccine; Biological: RH5.1 10μg adjuvated with 50μg Matrix-M; Biological: RH5.2 5μg adjuvated with 50μg Matrix-M Sponsor: University of Oxford Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 30, 2023 Category: Research Source Type: clinical trials
A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.
Condition: Malaria,Falciparum Interventions: Biological: Rabies vaccine; Biological: RH5.1 10μg adjuvated with 50μg Matrix-M; Biological: RH5.2 5μg adjuvated with 50μg Matrix-M Sponsor: University of Oxford Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 30, 2023 Category: Research Source Type: clinical trials